| 2023 |
Palmieri M, Joseph TE, O'Brien CA, Gomez-Acevedo H, Kim H-N, Manolagas SC, Ambrogini E. Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass. Bone. May 2023;170:116702. |
0 |
0 |
| 2023 |
Palmieri M, Joseph TE, O'Brien CA, Gomez-Acevedo H, Kim H-N, Manolagas SC, Ambrogini E. Retraction notice to “Deletion of the scavenger receptor Scarb1 in myeloid cells does not affect bone mass” [Bone 170(2023) 116702]. Bone. November 2023;176:116885. |
0 |
0 |
| 2005 |
Bellido T, Ali AA, Gubrij I, Plotkin LI, Fu Q, O’Brien CA, Manolagas SC, Jilka RL. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology. November 2005;146(11):4577-4583. |
44 |
35 |
| 2000 |
Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. April 2000;21(2):115-137. |
130 |
126 |
| 2010 |
Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. June 2010;31(3):266-300. |
25 |
24 |
| 1998 |
Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res. May 1998;13(5):793-802. |
34 |
27 |
| 2006 |
Aguirre JI, Plotkin LI, Stewart SA, Weinstein RS, Parfitt AM, Manolagas SC, Bellido T. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res. April 2006;21(4):605-615. |
67 |
62 |
| 2020 |
Ponte F, Kim H, Iyer S, Han L, Almeida M, Manolagas SC. Cxcl12 deletion in mesenchymal cells increases bone turnover and attenuates the loss of cortical bone caused by estrogen deficiency in mice. J Bone Miner Res. August 2020;35(8):1441-1451. |
1 |
1 |
| 2021 |
Palmieri M, Kim H, Gomez‐Acevedo H, Que X, Tsimikas S, Jilka RL, Manolagas SC, Witztum JL, Ambrogini E. A neutralizing antibody targeting oxidized phospholipids promotes bone anabolism in chow‐fed young adult mice. J Bone Miner Res. January 2021;36(1):170-185. |
1 |
0 |
| 1998 |
Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone. J Clin Invest. July 15, 1998;102(2):274-282. |
55 |
47 |
| 1999 |
Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest. August 1999;104(4):439-446. |
62 |
52 |
| 1999 |
Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. November 1999;104(10):1363-1374. |
45 |
37 |
| 2011 |
Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA. Matrix-embedded cells control osteoclast formation. Nat Med. November 2011;17(10):1235-1242. |
76 |
73 |
| 1995 |
Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. NEJM. February 2, 1995;332(5):305-311. |
35 |
32 |
| 1992 |
Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. July 3, 1992;257(5066):88-91. |
31 |
25 |